Seiichiro Ozono

Morinomiya Hospital — Japan

Medicine · Health Sciences

40h-index4.8kcitations298works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal cell carcinoma treatment(63), Bladder and Urothelial Cancer Treatments(60), Urinary Bladder and Prostate Research(44), Urinary and Genital Oncology Studies(29), Renal and related cancers(28)

Publications295 total

Differences in the approaches of cancer specialists toward adolescent and young adult cancer care
Pediatrics International·2021· 2 cited
Clinical significance of programmed death‐1 and programmed death‐ligand 1 expression in the tumor microenvironment of clear cell renal cell carcinoma
Cancer Science·2019· 46 citedOpen Access
Correction to: Current situation of cancer among adolescents and young adults in Japan
International Journal of Clinical Oncology·2018Open Access
Isosamidin, an extract of Peucedanum japonicum, may have pharmacological potency in the treatment of male lower urinary tract symptoms
ics.org·2018
Clinical Outcomes in Patients With Metastatic Papillary Renal-Cell Carcinoma: A Multi-Institutional Study in Japan
Clinical Genitourinary Cancer·2018· 7 cited
Current situation of cancer among adolescents and young adults in Japan
International Journal of Clinical Oncology·2018· 22 cited
NCCN Asia Consensus Statement prostate cancer
Japanese Journal of Clinical Oncology·2018· 21 citedOpen Access
Oral 5‐aminolevulinic acid‐mediated photodynamic diagnosis using fluorescence cystoscopy for non‐muscle‐invasive bladder cancer: A multicenter phase III study
International Journal of Urology·2018· 89 citedOpen Access
Clinical evaluation of two consecutive UroVysion fluorescence in situ hybridization tests to detect intravesical recurrence of bladder cancer: a prospective blinded comparative study in Japan
International Journal of Clinical Oncology·2018· 16 cited
[Current Status of Oncofertility in Adolescent and Young Adult (AYA) Generation Cancer Patients in Japan - National Survey of Oncologists].
PubMed·2018· 1 cited
Efficacy and safety of 3‐month dosing regimen of degarelix in Japanese subjects with prostate cancer: A phase III study
Cancer Science·2018· 21 citedOpen Access
Isosamidin, an extract of <i>Peucedanum japonicum</i>, inhibits phenylephrine‐mediated contractions of the human prostate in vitro
Phytotherapy Research·2018· 7 cited
筋層非浸潤性膀胱癌に対する蛍光膀胱鏡を用いた経口5-アミノレブリン酸媒介光線力学診断:多施設第III相試験
2018
[II .Problems of Treatment for Non-Muscle Invasive Bladder Cancer].
PubMed·2018
The Inverse Association between the Baseline Renal Function and Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with Molecular-Targeted Agents
Current Urology·2017· 2 citedOpen Access
Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup analysis from the CheckMate 025 study
Japanese Journal of Clinical Oncology·2017· 61 citedOpen Access
Drug therapy for renal cell carcinoma in the elderly.
PubMed·2017
MP94-09 ROLE OF THE SEROTONERGIC SYSTEM IN URETHRAL CONTINENCE REFLEXES DURING SNEEZING IN RATS
The Journal of Urology·2017
MP71-18 DISTRIBUTION OF LYMPH NODE METASTASIS IN UPPER URINARY TRACT UROTHELIAL CANCER, SUB-ANALYSIS OF JCOG1110A STUDY
The Journal of Urology·2017
PD24-01 COMPARATIVE ASSESSMENT OF EFFICACIES BETWEEN TWO ALTERNATIVE THERAPEUTIC SEQUENCES WITH NOVEL ANDROGEN RECEPTOR-AXIS-TARGETED AGENTS IN PATIENTS WITH CHEMOTHERAPY-NAIVE METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
The Journal of Urology·2017
page 1 of 15Next →

Frequent Co-authors

Tatsuya Takayama(9), Seiji Naito(9), Yoshihiko Hirao(9), Kiyohide Fujimoto(8), Nobuo Shinohara(7), Atsushi Otsuka(7), Yoshihiko Tomita(6), Soichi Mugiya(6), Hitoshi Shinbo(5), Tomoyasu Tsushima(5), Hirotsugu Uemura(4), Tatsuo Igarashi(4), Hideaki Miyake(4), Masato Fujisawa(4), Hideyuki Akaza(4), Momokazu Gotoh(4), Hirofumi Koga(4), Naoya Masumori(4), Hideyasu Matsuyama(4), Hiroshi Furuse(4)